Dr. Janet Martin to join international scientific program planning committee for upcoming EBHC

Click here for more information about the 7th Annual EBHC Conference. Early registration starts Dec 31, 2014. 

Dr. Janet Martin is the Director of the MEDICI (Medical Evidence Decision Integrity Clinical Impact),  

and this is certainly not the first of many fruitful international collaborations for the MEDICI group. The group has collaborated with many investigative teams world-wide on evidence-based systematic reviews and consensus statements. These forums provide a unique opportunity to teach surgeons, anesthesiologists and related healthcare personnel about evidence-based decision-making, meta-analysis and systematic review.

In 2011 with the support of the Schulich School of Medicine and Dentistry (SSMD), London Health Sciences Centre (LHSC) and Lawson Research, we are establishing a MEDICI Centre (Medical Evidence, Decision Integrity, Clinical Impact) to be the first hospital-based, evidence-based health technology assessment program in Ontario. This program will seek to involve other hospitals and the Ministry of Health and Long-term Care (MOHLTC) to build network capacity to answer high priority healthcare questions in a timely, transparent and accountable manner.

Evidence-based Decision Making and Health Technology Assessment (HTA) workshops and courses at the Schulich School of Medicine and Dentistry and cross-faculty within Western, will be established and likewise, a network with an international consortium of universities to provide an International MSc (HTA) program. The Network will generate new hypotheses for innovative research in applied decision-making and knowledge translation techniques to address key evidence gaps and translation gaps related to the constant tension between available technologies and resources in healthcare.

Read more about the MEDICI group and review their recent publications and research initiatives.